CYIENT.NS | Cyient Limited Annual & Quarterly Balance

Annual Balance Sheets

(In INR)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	70.03 Billion	65.48 Billion	47.87 Billion	44.92 Billion	41.79 Billion	38.89 Billion
Total Current Assets	35.59 Billion	31.91 Billion	28.97 Billion	28.51 Billion	24.65 Billion	25.85 Billion
Cash And Short Term Investments	10.59 Billion	13.43 Billion	13 Billion	14.38 Billion	13.92 Billion	9.35 Billion
Cash and Cash Equivalents	9.83 Billion	6.21 Billion	12.13 Billion	14.38 Billion	8.99 Billion	9.07 Billion
Short Term Investments	758 Million	7.22 Billion	866 Million	3.08 Billion	4.93 Billion	278 Million
Net Receivables	12.61 Billion	11.27 Billion	11.33 Billion	11.13 Billion	7.26 Billion	14.62 Billion
Inventory	4.67 Billion	4.35 Billion	2.79 Billion	1.58 Billion	2.26 Billion	1.83 Billion
Other Current Assets	7.7 Billion	2.84 Billion	1.84 Billion	1.41 Billion	1.19 Billion	41 Million
Total Non-Current Assets	34.44 Billion	33.56 Billion	18.9 Billion	16.41 Billion	17.14 Billion	13.03 Billion
Net PPE	7.74 Billion	7.27 Billion	6.92 Billion	7.29 Billion	7.7 Billion	3.83 Billion
Good Will And Intangible Assets	21.08 Billion	21.41 Billion	6.66 Billion	7.19 Billion	6.8 Billion	6.99 Billion
Good Will	16.69 Billion	16.36 Billion	6.18 Billion	5.83 Billion	5.37 Billion	5.25 Billion
Intangible Assets	4.39 Billion	5.05 Billion	477 Million	1.36 Billion	1.42 Billion	1.73 Billion
Long-Term Investments	3.94 Billion	3.46 Billion	3.58 Billion	344 Million	414 Million	270 Million
Tax Assets	752 Million	482 Million	248 Million	319 Million	396 Million	294 Million
Other Non Current Assets	910 Million	932 Million	1.48 Billion	1.26 Billion	1.82 Billion	1.65 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	24.46 Billion	30.84 Billion	16.73 Billion	15.38 Billion	16.22 Billion	13.31 Billion
Total Current Liabilities	16.58 Billion	20.23 Billion	12.62 Billion	11.09 Billion	11.13 Billion	9.89 Billion
Account Payables	6.87 Billion	7.14 Billion	5.25 Billion	4.53 Billion	3.72 Billion	3.71 Billion
Tax Payables	562 Million	570 Million	350 Million	296 Million	328 Million	424 Million
Short Term Debt	2.62 Billion	5.27 Billion	3.97 Billion	3.36 Billion	3.55 Billion	2.56 Billion
Deferred Revenue	562 Million	3.74 Billion	2.55 Billion	2.43 Billion	1.72 Billion	2.97 Billion
Other Current Liabilities	6.51 Billion	4.06 Billion	828 Million	765 Million	2.13 Billion	639 Million
Total Non Current Liabilities	7.88 Billion	10.61 Billion	4.11 Billion	4.29 Billion	5.08 Billion	3.42 Billion
Long-Term Debt	2.78 Billion	6.89 Billion	1.75 Billion	2.41 Billion	3.15 Billion	1.11 Billion
Deferred Revenue Non Current	2.46 Billion	7.82 Billion	261 Million	1.53 Billion	1.53 Billion	1.85 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.79 Billion	-4.93 Billion	1.75 Billion	166 Million	24 Million	48 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	45.56 Billion	34.63 Billion	31.13 Billion	29.54 Billion	25.57 Billion	25.57 Billion
Stock Holders Equity	42.58 Billion	34.66 Billion	31.16 Billion	29.57 Billion	25.6 Billion	25.59 Billion
Common Stock	555 Million	553 Million	552 Million	550 Million	550 Million	552 Million
Retained Earnings	31.63 Billion	24.84 Billion	22.37 Billion	20.21 Billion	21.79 Billion	16.51 Billion
Accumulated other comprehensive income	42.02 Billion	7.79 Billion	6.89 Billion	6.7 Billion	-5.14 Billion	-4.79 Billion
Common Stock Equity	42.58 Billion	34.66 Billion	31.16 Billion	29.57 Billion	25.6 Billion	25.59 Billion
Capital Lease Obligation	2.46 Billion	2.84 Billion	2.47 Billion	2.59 Billion	2.96 Billion	-
Total Investments	4.7 Billion	3.71 Billion	3.83 Billion	344 Million	424 Million	267 Million
Total Debt	7.87 Billion	12.17 Billion	5.73 Billion	5.77 Billion	6.7 Billion	3.68 Billion
Net Debt	-1.95 Billion	5.96 Billion	-6.4 Billion	-8.61 Billion	-2.29 Billion	-5.38 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	75.51 Billion	70.68 Billion	70.03 Billion	70.03 Billion	71.89 Billion	70.88 Billion
Total Current Assets	41.05 Billion	5.66 Billion	35.59 Billion	35.59 Billion	37.2 Billion	37.55 Billion
Cash And Short Term Investments	19.19 Billion	5.66 Billion	10.59 Billion	10.59 Billion	11.22 Billion	17.27 Billion
Cash and Cash Equivalents	11.64 Billion	10.09 Billion	9.83 Billion	9.83 Billion	10.58 Billion	5.1 Billion
Short Term Investments	7.54 Billion	521 Million	758 Million	758 Million	647 Million	12.16 Billion
Net Receivables	13.61 Billion	12.58 Billion	12.61 Billion	12.61 Billion	13.39 Billion	12.22 Billion
Inventory	5.3 Billion	5.26 Billion	4.67 Billion	4.67 Billion	4.9 Billion	4.68 Billion
Other Current Assets	16.55 Billion	8.19 Billion	7.7 Billion	7.7 Billion	7.67 Billion	3.37 Billion
Total Non-Current Assets	34.46 Billion	-5.66 Billion	34.44 Billion	34.44 Billion	34.68 Billion	33.33 Billion
Net PPE	7.39 Billion	11.81 Billion	7.74 Billion	7.74 Billion	12.15 Billion	7.17 Billion
Good Will And Intangible Assets	21.73 Billion	16.73 Billion	21.08 Billion	21.08 Billion	16.83 Billion	20.94 Billion
Good Will	17.51 Billion	16.73 Billion	16.69 Billion	16.69 Billion	16.83 Billion	16.3 Billion
Intangible Assets	4.22 Billion	-	4.39 Billion	4.39 Billion	-	4.64 Billion
Long-Term Investments	3.51 Billion	3.58 Billion	3.94 Billion	3.94 Billion	3.74 Billion	-8.12 Billion
Tax Assets	855 Million	729 Million	752 Million	752 Million	709 Million	600 Million
Other Non Current Assets	964 Million	-38.53 Billion	910 Million	910 Million	1.23 Billion	12.73 Billion
Other Assets	-	70.68 Billion	-	-	-	-
Total Liabilities	19.65 Billion	-45.56 Billion	24.46 Billion	24.46 Billion	27.9 Billion	27.58 Billion
Total Current Liabilities	14.89 Billion	16.56 Billion	16.58 Billion	16.58 Billion	19.18 Billion	19.12 Billion
Account Payables	5.58 Billion	5.91 Billion	6.87 Billion	6.87 Billion	6.42 Billion	6.58 Billion
Tax Payables	1.07 Billion	-	562 Million	562 Million	-	750 Million
Short Term Debt	2.76 Billion	4.87 Billion	2.62 Billion	2.62 Billion	3.85 Billion	4.38 Billion
Deferred Revenue	1.07 Billion	-	562 Million	562 Million	-	4.66 Billion
Other Current Liabilities	5.47 Billion	5.77 Billion	6.51 Billion	6.51 Billion	8.9 Billion	3.48 Billion
Total Non Current Liabilities	4.76 Billion	-45.56 Billion	7.88 Billion	7.88 Billion	8.71 Billion	8.46 Billion
Long-Term Debt	-	2 Billion	2.78 Billion	2.78 Billion	3.92 Billion	6 Billion
Deferred Revenue Non Current	-	2.43 Billion	2.46 Billion	2.46 Billion	2.28 Billion	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	3.96 Billion	-50.7 Billion	1.79 Billion	1.79 Billion	1.71 Billion	1.66 Billion
Other Liabilities	-	-16.56 Billion	-	-	-	-
Total Equity	55.85 Billion	45.56 Billion	45.56 Billion	45.56 Billion	43.98 Billion	43.3 Billion
Stock Holders Equity	51.4 Billion	45.56 Billion	42.58 Billion	42.58 Billion	43.98 Billion	40.37 Billion
Common Stock	555 Million	555 Million	555 Million	555 Million	554 Million	554 Million
Retained Earnings	-	-	31.63 Billion	31.63 Billion	-	-
Accumulated other comprehensive income	-	42.58 Billion	42.02 Billion	42.02 Billion	40.37 Billion	39.82 Billion
Common Stock Equity	51.4 Billion	45.56 Billion	42.58 Billion	42.58 Billion	43.98 Billion	40.37 Billion
Capital Lease Obligation	2.94 Billion	2.43 Billion	2.46 Billion	2.46 Billion	2.28 Billion	2.76 Billion
Total Investments	3.51 Billion	4.1 Billion	4.7 Billion	4.7 Billion	4.39 Billion	4.04 Billion
Total Debt	2.76 Billion	9.31 Billion	7.87 Billion	7.87 Billion	10.06 Billion	10.39 Billion
Net Debt	-8.88 Billion	-775 Million	-1.95 Billion	-1.95 Billion	-519 Million	5.28 Billion

Balance Sheet Charts

Roopa Industries Limited

ROOPAIND

Full Analysis

Annual Balance Sheets
Soaring Technology Co.,Ltd.

6222

Full Analysis

Annual Balance Sheets
Carclo plc

CAR

Full Analysis

Annual Balance Sheets
Black Box Limited

BBOX

Full Analysis

Annual Balance Sheets
UroGen Pharma Ltd.

URGN

Full Analysis

Annual Balance Sheets
Ocean Biomedical, Inc.

OCEAW

Full Analysis

Annual Balance Sheets

Global Stocks Search

Cyient Limited (CYIENT.NS)

Annual Balance Sheets

Balance Sheet Charts

Roopa Industries Limited

Soaring Technology Co.,Ltd.

Carclo plc

Black Box Limited

UroGen Pharma Ltd.

Ocean Biomedical, Inc.